Veracyte, Inc.
VCYT
$46.16
-$0.23-0.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.31% | 13.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.31% | 13.71% | |||
| Cost of Revenue | 0.41% | 16.52% | |||
| Gross Profit | 1.68% | 12.60% | |||
| SG&A Expenses | -11.96% | 10.27% | |||
| Depreciation & Amortization | 1.25% | 2.53% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.12% | 8.86% | |||
| Operating Income | 61.49% | 77.79% | |||
| Income Before Tax | 1,411.12% | -83.17% | |||
| Income Tax Expenses | -111.12% | 485.30% | |||
| Earnings from Continuing Operations | 2,052.76% | -113.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2,052.76% | -113.91% | |||
| EBIT | 61.49% | 77.79% | |||
| EBITDA | 43.32% | 47.64% | |||
| EPS Basic | 2,044.80% | -113.84% | |||
| Normalized Basic EPS | 23.12% | 64.95% | |||
| EPS Diluted | 2,020.00% | -113.89% | |||
| Normalized Diluted EPS | 21.67% | 69.14% | |||
| Average Basic Shares Outstanding | 0.43% | 0.47% | |||
| Average Diluted Shares Outstanding | 1.66% | -2.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||